Company
Headquarters: Shanghai, China
Employees: 743
CEO: Mr. Kuk Sing Ho
HK$1.20 Billion
HKD as of July 1, 2024
US$153.0 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.67 B |
| Cencora, Inc. | $43.82 B |
| Cardinal Health, Inc. | $23.31 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
| Sinopharm Group Co. Ltd | $8.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business. It offers IVD analyzers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance services, such as maintenance and repair, installation, and end customer training services, as well as consultancy services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents under the IVD brand. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
IVD Medical Holding Ltd has the following listings and related stock indices.
Stock: HKEX: 1931 wb_incandescent